制定控股公司
US ˙ NasdaqGS ˙ US29249E1091

簡介

本頁面提供了有關 Hafrun Fridriksdottir 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Hafrun Fridriksdottir已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Executive VP, Global R&D 1,387
US:ACT / Enact Holdings, Inc. SVP, GLOBAL R&D 6,914
Sr VP, Global Generics R&D 0
如何解讀這些圖表

以下圖表顯示了在Hafrun Fridriksdottir進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

ACT / Enact Holdings, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 ACT / Enact Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACT / Enact Holdings, Inc. Insider Trades
ACT / Enact Holdings, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 ACT / Enact Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACT / Enact Holdings, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Hafrun Fridriksdottir 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2022-05-19 2022-05-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -130,000 1,387 -98.94 8.22 -1,068,067 11,391
2022-03-08 2022-03-07 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -8,941 126,087 -6.62 7.37 -65,866 928,842
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -23,764 71,293 -25.00
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 23,764 135,028 21.36
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 140,750 140,750
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -18,905 18,906 -50.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -51,488 0 -100.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,618 111,264 -5.61 7.48 -49,519 832,529
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 18,905 117,882 19.10
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -18,020 98,977 -15.40 7.48 -134,835 740,592
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 51,488 116,997 78.60
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -21,682 43,366 -33.33
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -7,590 65,509 -10.38 8.14 -61,799 533,383
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 21,682 73,099 42.17
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -16,121 0 -100.00
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,116 51,417 -10.63 9.06 -55,412 465,844
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 16,121 57,533 38.93
2022-02-10 2022-02-08 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 51,488 51,488
2021-08-12 2021-08-10 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -50,860 41,412 -55.12 9.95 -506,021 412,016
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -37,884 0 -100.00
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -19,066 92,272 -17.12 10.22 -194,830 942,895
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 37,884 111,338 51.58
2021-03-08 2021-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 95,057 95,057
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -18,905 37,811 -33.33
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,515 73,454 -11.47 10.57 -100,536 776,117
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 18,905 82,969 29.51
2021-03-04 2021-03-02 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -50,000 64,064 -43.84 10.82 -540,890 693,026
2021-03-02 2021-03-01 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -10,912 114,064 -8.73 10.83 -118,186 1,235,399
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -21,682 65,048 -25.00
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 21,682 124,976 20.99
2021-02-17 2021-02-16 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,098 103,294 -1.99 11.12 -23,336 1,148,923
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -5,355 0 -100.00
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 5,355 105,392 5.35
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 37,884 37,884
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -16,120 16,121 -50.00
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -23,639 100,037 -19.11 12.69 -300,085 1,269,914
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -5,857 123,676 -4.52 12.69 -74,352 1,569,999
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
A - Award 67,852 129,533 110.01
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 16,120 61,681 35.38
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -266 0 -100.00
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -748 0 -100.00
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -134 45,561 -0.29 7.16 -960 326,373
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -380 45,695 -0.82 7.16 -2,722 327,333
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 266 46,075 0.58
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 748 45,809 1.66
2020-03-03 2020-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 86,730 86,730
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -17,850 0 -100.00
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -5,353 5,355 -49.99
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -8,825 45,061 -16.38 12.14 -107,155 547,134
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,647 53,886 -4.68 12.14 -32,140 654,289
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 17,850 56,533 46.14
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 5,353 38,683 16.06
2020-02-13 2020-02-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 17,850 17,850
2020-02-11 2020-02-10 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -5,544 33,330 -14.26 12.27 -68,025 408,953
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -16,120 32,241 -33.33
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 16,120 38,874 70.85
2020-01-02 2019-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -4,640 0 -100.00
2020-01-02 2019-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,459 22,754 -9.75 9.92 -24,396 225,742
2020-01-02 2019-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 4,640 25,213 22.55
2019-12-03 2019-12-02 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -4,310 20,573 -17.32 10.49 -45,214 215,818
2019-12-03 2019-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -8,133 0 -100.00
2019-12-03 2019-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 8,133 24,883 48.56
2019-03-19 2019-03-18 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -93 16,750 -0.55 16.63 -1,546 278,462
2019-03-19 2019-03-18 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -263 16,843 -1.54 16.63 -4,372 280,008
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -265 266 -49.91
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -747 748 -49.97
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 265 17,106 1.57
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 747 16,841 4.64
2019-03-06 2019-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 56,716 56,716
2019-03-05 2019-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -1,165 0 -100.00
2019-03-05 2019-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -409 16,094 -2.48 16.88 -6,905 271,712
2019-03-05 2019-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 1,165 16,503 7.60
2019-02-19 2019-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -5,353 10,708 -33.33
2019-02-19 2019-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -1,841 15,338 -10.72 17.67 -32,529 270,999
2019-02-19 2019-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 5,353 17,179 45.27
2019-01-03 2019-01-02 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -1,643 11,826 -12.20 15.70 -25,799 185,690
2019-01-03 2018-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -4,640 4,640 -50.00
2019-01-03 2018-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 4,640 13,469 52.56
2018-12-04 2018-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -2,711 8,133 -25.00
2018-12-04 2018-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -933 8,829 -9.56 21.76 -20,304 192,127
2018-12-04 2018-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 2,711 9,762 38.45
2018-03-20 2018-03-19 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -91 7,051 -1.27 17.88 -1,627 126,049
2018-03-20 2018-03-19 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -257 7,142 -3.47 17.88 -4,595 127,676
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -265 531 -33.29
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -747 1,495 -33.32
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 265 7,399 3.71
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 747 7,134 11.70
2018-03-06 2018-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -3,432 0 -100.00
2018-03-06 2018-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
F - Taxes -1,155 6,387 -15.32 19.38 -22,384 123,771
2018-03-06 2018-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
F - Taxes -400 7,542 -5.04 19.38 -7,752 146,155
2018-03-06 2018-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 3,432 7,942 76.11
2018-03-06 2018-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -1,165 1,165 -50.00
2018-03-06 2018-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 1,165 4,510 34.83
2018-03-06 3/A TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
3,345
2018-02-12 2018-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 48,361 48,361
2018-02-12 2018-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Stock Options (right to buy)
A - Award 123,288 123,288
2018-01-08 3/A TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
3,342
2018-01-02 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
6,692
2018-01-02 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
6,692
2014-05-13 2014-05-09 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 1,269 6,914 22.48 197.05 250,056 1,362,404
2013-10-03 2013-10-01 4 ACT Actavis plc
Ordinary Shares
A - Award 5,645 5,645
2013-10-02 2013-10-01 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
D - Sale to Issuer -5,645 0 -100.00
2013-10-02 2013-09-30 4 ACT Actavis, Inc.
Restricted Stock Units
M - Exercise -5,110 0 -100.00
2013-10-02 2013-09-30 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
F - Taxes -5,510 5,645 -49.39 144.00 -793,440 812,880
2013-10-02 2013-09-30 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
M - Exercise 5,110 11,155 84.53
2013-10-02 2013-09-30 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
A - Award 4,318 6,045 250.03
2013-10-02 2012-12-05 4 ACT Actavis, Inc.
Restricted Stock Units
A - Award 5,110 5,110
2013-03-08 2013-03-06 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
A - Award 1,727 1,727
2012-11-05 3 WPI WATSON PHARMACEUTICALS INC
No securities beneficially owned
0
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)